Consistently, plasma H19 levels were found to decrease significantly after surgery, and they have been significantly correlated with ER, PR, Her-2, and lymph node metastasis, indicating the potential use of H19 as a diagnostic and monitoring biomarker for breast cancer (174). Here, H19 is linked to metastatic malignant neoplasm in the lymph nodes.